Company intelligence / Profile preview

Newport Pharmaceuticals Limited

Ownership
Private
Employees
~15
Development stage
Commercial
01

Overview

Newport Pharmaceuticals Limited, based in Dublin, Ireland, has operated for over 30 years. Its lead product, Inosine Acedoben Dimepranol (IAD), has been licensed internationally since the early 1970s to treat cell-mediated immune deficiencies linked to viral infections. The company continues to generate clinical data on IAD for niche applications and explores new formulations and manufacturing optimizations. It maintains a specialty pharma focus with strategic operations targeting Central Eastern Europe.

Therapeutic areas
Immunology
Modalities
Small molecules (notably Inosine Acedoben Dimepranol - IAD)
Industry
Biotech
02

Drug pipeline

2 assets

inosine pranobex (Newport Pharmaceuticals Limited)

Unknown

1 more asset in the full pipeline.

Request access →
03

Partnerships

Ewopharma mentioned as an innovative partner for marketing pharmaceuticals in Switzerland and Central Eastern Europe; possible distribution/marketing partnership but not confirmed as exclusive or formal joint venture.

Beyond the preview

Go deeper on Newport Pharmaceuticals Limited.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Newport Pharmaceuticals Limited.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call